ConductScience.org, home

Gene · 389421

NIH grants1,664

NIH grants whose papers are about the gene, through NIH's grant-paper links.

561 to 580 of 1,664

Download this page as JSON
GrantTitleLIN28B papersNewest fiscal year
R01CA214019Novel NFAT1-MDM2 inhibitor for Breast Cancer Therapy12021
R01CA214965The role and mechanism of FTO in leukemogenesis and drug response12021
R01CA215186LIN28 and RNA Uridylation in Breast Cancer: Mouse Models and Molecular Analyses12021
R01CA229739Development of small molecules to target KDM4B12021
R01DK113645Hepatitis C virus infection and mechanism of liver disease progression12021
R01DK114468Defining the Niche-dependent Role of RNA Editing in Aged and MDS Hematopoietic Stem and Progenitor Cell Dysfunction12021
R01DK115445Pathogenic Heterogeneity in Mucosal Stem Cells in Pediatric Crohn's Disease12021
R01ES014370Effects of Environmental Phthalates and Chemical Mixtures on Male Puberty and Semen Quality12021
R01EY022694Mechanisms of Retinal Neuronal Injury12021
R01EY027347Reprogramming retinal ganglion cells for optic nerve regeneration and guidance12021
R01EY029548Computational Tools for Single Cell Analysis: Application to Retinal Degeneration12021
R01GM122776Epigenetic Regulation of Gene Expression during Spermatogenesis12021
R01GM124486Single-nucleotide resolution mapping of allelic protein-RNA interactions and splicing-regulatory variants12021
R01HD088549VEGF signaling in placental development and disease12021
R01HD090071Delayed Puberty: Causes and Consequences, Genotypes and Phenotypes12021
R01HG009979Cytoscape: A Modeling Platform for Biomolecular Networks12021
R01HL067245Regulation of Signal Transduction to Treat Heart Failure12021
R01HL136652Biodegradable nanoparticles, a genome editing platform to treat hemophilia12021
R01HL137223Analysis of RNA binding proteins directing hematopoietic stem cell fate12021
R01HL142673Control of Endothelial Mechanotransduction by the Mitochondrial Ca2+ Uniporter: Implications for Atherosclerosis12021

Source NIH's project filesgene-search-2026-11-11-0.2.0

Sources 12

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
  • GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
  • HGNCCC0
  • NCBI GenePublic domain (US government)
  • NIH's project files and grant-paper linksPublic domain
  • Open TargetsCC0 1.0
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
  • GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
  • HGNCCC0: https://www.genenames.org/about/license/
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this list from software.

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/genes/v1/389421/grants?page=29